|
2024
|
Invention
|
Therapeutic combination comprising 4-(4-methyl-piperazin-1-yl)-n-{6-[2-(4-trifluoromethyl-benzylo... |
|
|
Invention
|
Salt of n-(2,6-diethylphenyl)-8-({4-[4-(dimethylamino) piperidin-1-yl]-2-methoxyphenyl}amino)-1-m... |
|
|
Invention
|
Use of a mps1 inhibitor for the treatment of hepatocellular carcinoma. The invention provides a l... |
|
2023
|
Invention
|
Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitor... |
|
|
Invention
|
Salts and polymorphs of 4-(4-methyl-piperazin-1-yl)-n-{6-[2-(4-trifluoromethyl-benzyloxy)-ethoxy]... |
|
|
Invention
|
Novel specifically substituted thiophenolic compounds. The present invention relates to novel thi... |
|
|
Invention
|
Substituted 3-amino indazole derivatives as kinase inhibitors. The present invention relates to s... |
|
2022
|
Invention
|
Anthracycline derivative linker reagents, antibody-drug conjugates and methods.
The present inve... |
|
|
Invention
|
Anthracycline derivative linker reagents, antibody-drug conjugates and methods. The present inven... |
|
|
Invention
|
N-(substituted-phenyl)-sulfonamide derivatives as kinase inhibitors. The invention relates to N-(... |
|
|
Invention
|
4-carboxamido-isoindolinone derivatives as selective parp-1 inhibitors. There are provided substi... |
|
|
Invention
|
Substituted pyrrole carboxamides, process for their preparation and their use as kinase inhibitor... |
|
2021
|
Invention
|
Pyrazolyl-pyrimidine derivatives as kinase inhibitors.
The present invention relates to pyrazoly... |
|
|
Invention
|
Pyrazolyl-pyrimidine derivatives as kinase inhibitors. The present invention relates to pyrazolyl... |
|
|
G/S
|
Pharmaceutical and veterinary preparations for treating
cancer, myocardium infarction and malari... |
|
|
G/S
|
Pharmaceutical and veterinary preparations for treating cancer, myocardium infarction and malaria... |
|
|
Invention
|
Substituted indazole derivatives active as kinase inhibitors.
Substituted indazole derivatives o... |
|
2020
|
Invention
|
Gem-disubstituted heterocyclic compounds and their use as idh inhibitors.
The present invention ... |
|
|
Invention
|
Gem-disubstituted heterocyclic compounds and their use as idh inhibitors. The present invention r... |
|
|
Invention
|
Crystalline form of n-[5-(3,5-difluoro-benzyl)-1h-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(te... |
|
2019
|
Invention
|
Heterocondensed pyridones compounds and their use as idh inhibitors. The present invention relate... |
|
|
Invention
|
Molecules for administration to ros1 mutant cancer cells. Substituted indazole derivatives of for... |
|
2018
|
Invention
|
Asymmetric process for the preparation of thieno-indoles derivatives. The present invention relat... |
|
|
Invention
|
Substituted pyrroles active as kinases inhibitors. The present invention relates to substituted p... |
|
|
Invention
|
Methods for treating neuroblastoma. Methods of treating neuroblastoma associated with a deregulat... |
|
|
Invention
|
Substituted pyrazolo[4,3-h]quinazolines as choline kinase inhibitors. The present invention relat... |
|
|
Invention
|
Pyrazolo-quinazoline derivatives as choline kinase inhibitors. The present invention relates to s... |
|
|
Invention
|
New salt of n-(2,6-diethylphenyl)-8-({4-[4-(dimethylamino)piperidin-1-yl]-2-methoxyphenyl}amino)-... |
|
|
Invention
|
Substituted indazole derivatives active as kinase inhibitiors. The present invention relates to s... |
|
2017
|
Invention
|
Purine and 3-deazapurine analogues as choline kinase inhibitors. There are provided substituted p... |
|
|
Invention
|
N-(substituted-phenyl)-sulfonamide derivatives as perk kinase inhibitors. The invention relates t... |
|
|
Invention
|
New crystalline form of n-[5-(3,5-difluoro-benzyl)-1h-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2... |
|
2005
|
G/S
|
[ bleaching preparations for laundry use; liquids, gels and powders for cleaning, polishing and s... |
|
|
G/S
|
Bleaching preparations and other substances for laundry use;
cleaning, polishing, scouring and a... |
